πŸ‡ΊπŸ‡Έ FDA
Patent

US 8840926

Sialic acid analogs

granted A61PA61P21/00

Quick answer

US patent 8840926 (Sialic acid analogs) held by Ultragenyx Pharmaceutical Inc. expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ultragenyx Pharmaceutical Inc.
Grant date
Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P21/00